Challenges in the Introduction of Next-Generation Sequencing (NGS) for Diagnostics of Myeloid Malignancies Into Clinical Routine Use
Blood Cancer Journal - United States
doi 10.1038/s41408-018-0148-6
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Springer Science and Business Media LLC